SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • 1
    Muszbek L, Adany R, Mikkola H. Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function. Crit Rev Clin Lab Sci 1996; 33: 357421.
  • 2
    Muszbek L, Bagoly Z, Bereczky Z, Katona E. The involvement of blood coagulation factor XIII in fibrinolysis and thrombosis. Cardiovasc Hematol Agents Med Chem 2008; 6: 190205.
  • 3
    Muszbek L, Yee VC, Hevessy Z. Blood coagulation factor XIII: Structure and function. Thromb Res 1999; 94: 271305.
  • 4
    Buluk K. An unknown action of blood platelets; preliminary communication. Pol Tyg Lek (Wars) 1955; 10: 191.
  • 5
    Kiesselbach TH, Wagner RH. Demonstration of factor XIII in human megakaryocytes by a fluorescent antibody technique. Ann N Y Acad Sci 1972; 202: 318328.
  • 6
    Muszbek L, Adany R, Szegedi G, Polgár J, Kávai M. Factor XIII of blood coagulation in human monocytes. Thromb Res 1985; 37: 401410.
  • 7
    Adany R, Belkin A, Vasilevskaya T, Muszbek L. Identification of blood coagulation factor XIII in human peritoneal macrophages. Eur J Cell Biol 1985; 38: 171173.
  • 8
    Henriksson P, Becker S, Lynch G, McDonagh J. Identification of intracellular factor XIII in human monocytes and macrophages. J Clin Invest 1985; 76: 528534.
  • 9
    Katona EE, Ajzner E, Toth K, Kárpáti L, Muszbek L. Enzyme-linked immunosorbent assay for the determination of blood coagulation factor XIII A-subunit in plasma and in cell lysates. J Immunol Methods 2001; 258: 127135.
  • 10
    Adany R, Kiss A, Muszbek L. Factor XIII: A marker of mono- and megakaryocytopoiesis. Br J Haematol 1987; 67: 167172.
  • 11
    Invernizzi R, De Fazio P, Iannone AM, Zambelli LM, Rastaldi MP, Ippoliti G, Ascari E. Immunocytochemical detection of factor XIII A—Subunit in acute leukemia. Leuk Res 1992; 16: 829836.
  • 12
    Kappelmayer J, Simon A, Katona E, Szanto A, Nagy L, Kiss A, Kiss C, Muszbek L. Coagulation factor XIII-A. A flow cytometric intracellular marker in the classification of acute myeloid leukemias. Thromb Haemost 2005; 94: 454459.
  • 13
    Kiss F, Simon A, Csathy L, Hevessy Z, Katona E, Kiss C, Kappelmayer J. A coagulation factor becomes useful in the study of acute leukemias: studies with blood coagulation factor XIII. Cytometry Part A 2008; 73A: 194201.
  • 14
    Paietta E. Expression of cell-surface antigens in acute promyelocytic leukaemia. Best Pract Res Clin Haematol 2003; 16: 369385.
  • 15
    Paietta E, Goloubeva O, Neuberg D, Bennett JM, Gallagher R, Racevskis J, Dewald G, Wiernik PH, Tallman MS. A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes. Cytometry Part B Clin Cytom 2004; 59B: 19.
  • 16
    Orfao A, Chillon MC, Bortoluci AM, López-Berges MC, García-Sanz R, Gonzalez M, Tabernero MD, García-Marcos MA, Rasillo AI, Hernández-Rivas J, et al. The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RARalpha gene rearrangements. Haematologica 1999; 84: 405412.
  • 17
    Polgar J, Hidasi V, Muszbek L. Non-proteolytic activation of cellular protransglutaminase (placenta macrophage factor XIII). Biochem J 1990; 267: 557560.
  • 18
    Kiss F, Hevessy Z, Veszpremi A, Katona E, Kiss C, Vereb G, Muszbek L, Kappelmayer J. Leukemic lymphoblasts, a novel expression site of coagulation factor XIII subunit A. Thromb Haemost 2006; 96: 176182.
  • 19
    Schwartz ML, Pizzo SV, Hill RL, McKee PA. The subunit structures of human plasma and platelet factor XIII (fibrin-stabilizing factor). J Biol Chem 1971; 246: 58515854.
  • 20
    Bagoly Z, Haramura G, Muszbek L. Down-regulation of activated factor XIII by polymorphonuclear granulocyte proteases within fibrin clot. Thromb Haemost 2007; 98: 359367.
  • 21
    Bagoly Z, Fazakas F, Komaromi I, Haramura G, Tóth E, Muszbek L. Cleavage of factor XIII by human neutrophil elastase results in a novel active truncated form of factor XIII A subunit. Thromb Haemost 2008; 99: 668674.
  • 22
    De Rossi G, Avvisati G, Coluzzi S, Fenu S, LoCoco F, Lopez M, Nanni M, Pasqualetti D, Mandelli F. Immunological definition of acute promyelocytic leukemia (FAB M3): A study of 39 cases. Eur J Haematol 1990; 45: 168171.
  • 23
    Erber WN, Asbahr H, Rule SA, Scott CS. Unique immunophenotype of acute promyelocytic leukaemia as defined by CD9 and CD68 antibodies. Br J Haematol 1994; 88: 101104.
  • 24
    Guglielmi C, Martelli MP, Diverio D, Fenu S, Vegna ML, Cantù--Rajnoldi A, Biondi A, Cocito MG, Del Vecchio L, Tabilio A, et al. Immunophenotype of adult and childhood acute promyelocytic leukaemia: Correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases. Br J Haematol 1998; 102: 10351041.
  • 25
    Oudijk EJ, Nieuwenhuis HK, Bos R, Fijnheer R. Elastase mediated fibrinolysis in acute promyelocytic leukemia. Thromb Haemost 2000; 83: 906908.